Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2021

20.08.2020 | Original Article

Impact of Health Insurance, Poverty, and Comorbidities on Colorectal Cancer Screening: Insights from the Medical Expenditure Panel Survey

verfasst von: Andrew J. Gawron, Judith Staub, Klaus Bielefeldt

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Despite national campaigns and other efforts to improve colorectal cancer (CRC) screening, participation rates remain below targets set by expert panels. We hypothesized that availability and practice patterns of healthcare providers may contribute to this gap.

Method

Using data of the Medical Expenditure Panel Survey for the years between 2000 and 2016, we extracted demographic, socioeconomic, and health-related data as well as reported experiences about barriers to care, correlating results with answers about recent participation in colorectal cancer screening. As CRC screening guidelines recommend initiation of testing at age 50, we focused on adults 50 years or older.

Results

We included responses of 163,564 participants for the period studied. There was a significant increase in CRC screening rates over time. Comorbidity burden, poverty, race, and ethnicity independently predicted participation in screening. Lack of insurance coverage and cost of care played an important role as reported barrier. Convenient access to care, represented by availability of appointments beyond typical business hours, and frequency of provider interactions, correlated with higher rates of screening.

Conclusion

Our data show a positive effect of educational efforts and healthcare reform with coverage of screening. Easy and more frequent access to individual providers predicted a higher likelihood of completed screening tests. This finding could translate into more widespread implementation of screening programs, as the increasingly common virtual care delivery offers a new and convenient option to patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145–164. Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145–164.
2.
Zurück zum Zitat Joseph DA, King JB, Richards TB, et al. Use of colorectal cancer screening tests by state. Prev Chronic Dis. 2018;15:E80.CrossRef Joseph DA, King JB, Richards TB, et al. Use of colorectal cancer screening tests by state. Prev Chronic Dis. 2018;15:E80.CrossRef
4.
Zurück zum Zitat Xu MR, Kelly AMB, Kushi LH, et al. Impact of the affordable care act on colorectal cancer outcomes: a systematic review. Am J Prev Med. 2020;58:596–603.CrossRef Xu MR, Kelly AMB, Kushi LH, et al. Impact of the affordable care act on colorectal cancer outcomes: a systematic review. Am J Prev Med. 2020;58:596–603.CrossRef
6.
Zurück zum Zitat Honein-AbouHaidar GN, Baxter NN, Moineddin R, et al. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011. Cancer Epidemiol. 2013;37:946–956.CrossRef Honein-AbouHaidar GN, Baxter NN, Moineddin R, et al. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011. Cancer Epidemiol. 2013;37:946–956.CrossRef
7.
Zurück zum Zitat Honein-AbouHaidar GN, Kastner M, Vuong V, et al. Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiol Biomark Prev. 2016;25:907–917.CrossRef Honein-AbouHaidar GN, Kastner M, Vuong V, et al. Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiol Biomark Prev. 2016;25:907–917.CrossRef
8.
Zurück zum Zitat Wang H, Roy S, Kim J, et al. Barriers of colorectal cancer screening in rural USA: a systematic review. Rural Remote Health. 2019;19:5181.PubMed Wang H, Roy S, Kim J, et al. Barriers of colorectal cancer screening in rural USA: a systematic review. Rural Remote Health. 2019;19:5181.PubMed
12.
Zurück zum Zitat Beydoun HA, Beydoun MA. Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control. 2008;19:339–359.CrossRef Beydoun HA, Beydoun MA. Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control. 2008;19:339–359.CrossRef
13.
Zurück zum Zitat Increased use of colorectal cancer tests–United States, 2002 and 2004. MMWR Morb Mortal Wkly Rep 55; 2006, no. 11, p. 308. Increased use of colorectal cancer tests–United States, 2002 and 2004. MMWR Morb Mortal Wkly Rep 55; 2006, no. 11, p. 308.
14.
Zurück zum Zitat Vital signs: colorectal cancer screening among adults aged 50-75 years—United States, 2008. MMWR Morb Mortal Wkly Rep 59; 2010, no 12, p. 808. Vital signs: colorectal cancer screening among adults aged 50-75 years—United States, 2008. MMWR Morb Mortal Wkly Rep 59; 2010, no 12, p. 808.
15.
Zurück zum Zitat Muthukrishnan M, Arnold LD, James AS. Patients’ self-reported barriers to colon cancer screening in federally qualified health center settings. Prev Med Rep. 2019;15:100896.CrossRef Muthukrishnan M, Arnold LD, James AS. Patients’ self-reported barriers to colon cancer screening in federally qualified health center settings. Prev Med Rep. 2019;15:100896.CrossRef
16.
Zurück zum Zitat Young WF, McGloin J, Zittleman L, et al. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network. J Rural Health. 2007;23:238–245.CrossRef Young WF, McGloin J, Zittleman L, et al. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network. J Rural Health. 2007;23:238–245.CrossRef
17.
Zurück zum Zitat Zerhouni YA, Trinh QD, Lipsitz S, et al. Effect of medicaid expansion on colorectal cancer screening rates. Dis Colon Rectum. 2019;62:97–103.CrossRef Zerhouni YA, Trinh QD, Lipsitz S, et al. Effect of medicaid expansion on colorectal cancer screening rates. Dis Colon Rectum. 2019;62:97–103.CrossRef
18.
Zurück zum Zitat Luthra S. Team Trump Says Administration’s Action on Health Care ‘Is Working.’ Is It? Kaiser Health News, January 13, 2020, 2020. Luthra S. Team Trump Says Administration’s Action on Health Care ‘Is Working.’ Is It? Kaiser Health News, January 13, 2020, 2020.
19.
Zurück zum Zitat Laszewski R. The Trump and Republican 2020 Health Care Plan. Forbes, January 5, 2020, 2020. Laszewski R. The Trump and Republican 2020 Health Care Plan. Forbes, January 5, 2020, 2020.
20.
Zurück zum Zitat Harewood GC, Wiersema MJ, Melton LJ 3rd. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol. 2002;97:3186–3194.CrossRef Harewood GC, Wiersema MJ, Melton LJ 3rd. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol. 2002;97:3186–3194.CrossRef
21.
Zurück zum Zitat Grobbee EJ, van der Vlugt M, van Vuuren AJ, et al. Diagnostic yield of one-time colonoscopy vs one-time flexible sigmoidoscopy vs multiple rounds of mailed fecal immunohistochemical tests in colorectal cancer screening. Clin Gastroenterol Hepatol. 2020;18(667–675):e1. Grobbee EJ, van der Vlugt M, van Vuuren AJ, et al. Diagnostic yield of one-time colonoscopy vs one-time flexible sigmoidoscopy vs multiple rounds of mailed fecal immunohistochemical tests in colorectal cancer screening. Clin Gastroenterol Hepatol. 2020;18(667–675):e1.
22.
Zurück zum Zitat Senore C, Inadomi J, Segnan N, et al. Optimising colorectal cancer screening acceptance: a review. Gut. 2015;64:1158–1177.CrossRef Senore C, Inadomi J, Segnan N, et al. Optimising colorectal cancer screening acceptance: a review. Gut. 2015;64:1158–1177.CrossRef
23.
Zurück zum Zitat Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019;156(254–272):e11. Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019;156(254–272):e11.
24.
Zurück zum Zitat Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575–582.CrossRef Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575–582.CrossRef
25.
Zurück zum Zitat Gupta S, Brenner AT, Ratanawongsa N, et al. Patient trust in physician influences colorectal cancer screening in low-income patients. Am J Prev Med. 2014;47:417–423.CrossRef Gupta S, Brenner AT, Ratanawongsa N, et al. Patient trust in physician influences colorectal cancer screening in low-income patients. Am J Prev Med. 2014;47:417–423.CrossRef
Metadaten
Titel
Impact of Health Insurance, Poverty, and Comorbidities on Colorectal Cancer Screening: Insights from the Medical Expenditure Panel Survey
verfasst von
Andrew J. Gawron
Judith Staub
Klaus Bielefeldt
Publikationsdatum
20.08.2020
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2021
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06541-7

Weitere Artikel der Ausgabe 1/2021

Digestive Diseases and Sciences 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.